Symbol Name ID |
Mios
meiosis regulator for oocyte development MGI:2182066 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Miostm1Pfw/Miostm1Pfw Olig2tm2(TVA,cre)Rth/Olig2+ involves: 129 * C57BL/6 |
abnormal oligodendrocyte physiology | J:320720 |
normal behavior/neurological phenotype | J:320720 | |
decreased oligodendrocyte number | J:320720 | |
dysmyelination | J:320720 | |
Miostm1Pfw/Miostm1Pfw Tg(Camk2a-cre)2Gsc/0 involves: C57BL/6 * FVB/N |
normal nervous system phenotype | J:320720 |
Miostm1Pfw/Miostm1Pfw Tg(Nes-cre)1Kln/0 involves: C57BL/6 * SJL |
abnormal forebrain morphology | J:320720 |
decreased brain size | J:320720 | |
decreased oligodendrocyte number | J:320720 | |
dysmyelination | J:320720 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|